# Seal and fish oils partially counteract inflammation and modulate endocannabinoidome lipid … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/seal-and-fish-oils-partially-counteract-inflammation-and-modulate-endocannabinoidome-lipid/ > **Published:** 2026-06-02T12:14:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-27T21:53:32-04:00 > **Clinical Summary:** How omega-3 oils modulate the endocannabinoid system and reduce inflammation. Implications for cannabis patients and clinical practice. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPainAnxietySafetyAgingNeurologyMental Health Why This Matters This research demonstrating that omega-3 rich oils modulate [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) function provides clinicians with evidence that dietary interventions may complement or enhance [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) for inflammatory conditions. Understanding how lipid metabolism affects endocannabinoid signaling helps explain variable patient responses to cannabinoid treatments and supports personalized approaches combining nutrition with [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). For patients, this suggests that omega-3 supplementation alongside [cannabinoid therapy](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/) may optimize anti-inflammatory outcomes and reduce reliance on higher cannabinoid doses. Clinical Summary This research demonstrates that seal and fish oils containing omega-3 fatty acids can partially mitigate inflammatory responses by modulating the endocannabinoidome, a broader lipid signaling system that includes but extends beyond classical endocannabinoids like anandamide and 2-AG. The study positions the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) as a key physiological integrator responding to environmental stressors, with the gut microbiome serving as an important mediator of these lipid-signaling pathways. These findings suggest that dietary manipulation through omega-3 supplementation may enhance the endogenous cannabinoid system’s natural anti-inflammatory capacity, potentially offering a non-pharmacologic adjunct to cannabinoid-based therapies. For clinicians considering cannabis for inflammatory conditions, this work indicates that patients’ dietary status and omega-3 intake may influence [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) function and treatment response. Understanding this nutritional-endocannabinoid interface could help optimize therapeutic outcomes in patients using cannabis for inflammation-related conditions by addressing modifiable dietary factors alongside [cannabinoid therapy](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/). Dr. Caplan’s Take “What this research tells us is that omega-3 fatty acids from marine sources can meaningfully influence endocannabinoid signaling, which means patients asking about cannabis as an anti-inflammatory tool should first be evaluated for basic nutritional deficiencies that might accomplish similar goals through diet alone. The endocannabinoid system doesn’t operate in isolation, and good [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) requires understanding how foundational metabolic factors either augment or diminish the therapeutic potential of any cannabinoid intervention.” Clinical Perspective This research exploring how seal and fish oils influence endocannabinoid system function through lipid modulation offers a mechanistic perspective on how omega-3 rich diets may affect cannabinoid homeostasis, though the clinical translation remains preliminary and context-dependent. The endocannabinoid system’s role in regulating inflammation and gut-microbiome interactions is increasingly recognized, but the specific contribution of dietary lipids to this pathway in human populations has not been definitively established, particularly across varying genetic backgrounds and baseline inflammatory states. Healthcare providers should recognize that while omega-3 supplementation has independent evidence supporting its use for certain inflammatory conditions, any anti-inflammatory benefit from modulating the endocannabinoidome through dietary means represents an emerging mechanism that does not yet justify changing standard dietary recommendations. The complexity of the endocannabinoid system, combined with individual variability in microbiome composition and metabolic capacity, means 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Seal%20and%20fish%20oils%20partially%20counteract%20inflammation%20and%20modulate%20endocannabinoidome%20lipid%20...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D57312)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D57312)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Seal%20and%20fish%20oils%20partially%20counteract%20inflammation%20and%20modulate%20endocannabinoidome%20lipid%20...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D57312)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.nature.com/articles/s41598-026-54447-7](https://www.nature.com/articles/s41598-026-54447-7) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).